LRRK2 and Parkinson disease: VPS35[D620N] knock-in cells and tissues display markedly enhanced Rab phosphorylation to a higher level than observed with LRRK2 PD pathogenic mutations (39,40), and this mutation has been proposed to lead to lysosomal dysfunction (41,42).